Originally it was considered that there might be one cause that explained all cases of MND. However it is now known that can’t be the case, and research is being undertaken to identify the multiple causes of the condition. A number of strategies and approaches are being tested around the world, both in the laboratory and in human clinical trials. As of 2012, intense research is being conducted on genetic factors, the role of the immune system and the role of cells other than nerve cells in this disease. In addition, therapies, such as “Aimspro” and other treatments are being tested for potential benefits in ALS.
Joost van der Westhuizen was diagnosed with motor neurone disease by neurologists in
South Africa and this was confirmed at the Cleveland Clinic in the US in 2011.
Importantly, Joost has the most severe form of the neurodegenerative disease
which led to an accelerated deterioration in his health.
Joost travelled to Harley Street in London in late April 2012 to see if
the aimspro treatment could help him. After receiving a once daily treatment of
Aimspro (administered by a subcutaneous injection), Joost's condition has been
stabilised with a degree of improvement being observed in the last two months
since starting treatment.
Muscle fasciculation, speech and fatigue have all improved. Daily
activities which we take for granted such as holding a cup or sandwich with one
hand, putting on a jacket, or buttoning up a shirt are no longer an issue with
Joost since initiating the treatment. More work clearly needs to be done but
this treatment which has recently completed two phase II clinical trials in the
UK may provide hope for patients with motor neurone disease in the future.
No comments:
Post a Comment